Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
20/07/2026 02:33
BRIEF-Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq July 20 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:
CLINUVEL'S ADS TO COMMENCE TRADING ON NASDAQ
ADS EXPECTED TO COMMENCE TRADING ON NASDAQ UNDER TICKER CUVL ON JULY 20
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist